FDA reverses ban on Juul's e-cigarette sales
Digest more
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising medications, the Congressional Budget Office said on Friday.
Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a CBO analysis.
The U.S. government is nixing a whole slew of "obsolete" U.S. food standards that Trump administration officials say also include "unnecessary" ones.
1h
Soy Aire on MSNFDA Issues High-Risk Recall Alert on Contaminated Fruits and VegetablesThe FDA has issued a high-risk recall alert for certain fruits and vegetables due to contamination concerns. Consumers are urged to exercise caution and stay informed about the potential health risks associated with these products.
The pharmaceutical company said it remained confident in the benefit and risk profile of Blenrep and will continue to work with the FDA.
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead. Yet another biopharma name has been run through a familiar trading cycle that often ends on a bullish note.
President Donald Trump's proposed budget cuts to the National Institutes of Health would eventually result in fewer drugs on the market, the U.S. Congressional Budget Office said on Friday.
US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels on Hormone Replacement Therapy.
Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) combinations. The belantamab mafodotin combinations were evaluated in adults with relapsed or refractory multiple myeloma who have received at least one prior line of therapy.
The U.S. Food and Drug Administration approved a new blue color additive derived from the fruit of the gardenia, a flowering evergreen, for use in a variety of drinks and candies.
WASHINGTON — The US Food and Drug Administration aims to revoke 52 standards of identity (SOI) across a swath of food categories, claiming the regulations are “obsolete and unnecessary.”
4d
Sportschosun on MSNLee Yeon-bok's Rice Soup and Food and Drug Administration's Suspension and Recovery…Nonconformity with bacterial and E. coli standardsLee Yeon-bok Rice Soup' was decided by the Ministry of Food and Drug Safety to withdraw the suspension of sales. The Ministry of Food and Drug Safety announced on the 15th that it has stopped selling some of its products and is taking measures to recover them.